Literature DB >> 33536542

Macrophage and adipocyte interaction as a source of inflammation in kidney disease.

Cristina Martos-Rus1, Goni Katz-Greenberg1, Zhao Lin2, Eurico Serrano1, Diana Whitaker-Menezes2, Marina Domingo-Vidal2, Megan Roche2, Kavitha Ramaswamy1, Douglas C Hooper3, Bonita Falkner1, Maria P Martinez Cantarin4.   

Abstract

In obesity, adipose tissue derived inflammation is associated with unfavorable metabolic consequences. Uremic inflammation is prevalent and contributes to detrimental outcomes. However, the contribution of adipose tissue inflammation in uremia has not been characterized. We studied the contribution of adipose tissue to uremic inflammation in-vitro, in-vivo and in human samples. Exposure to uremic serum resulted in activation of inflammatory pathways including NFκB and HIF1, upregulation of inflammatory cytokines/chemokines and catabolism with lipolysis, and lactate production. Also, co-culture of adipocytes with macrophages primed by uremic serum resulted in higher inflammatory cytokine expression than adipocytes exposed only to uremic serum. Adipose tissue of end stage renal disease subjects revealed increased macrophage infiltration compared to controls after BMI stratification. Similarly, mice with kidney disease recapitulated the inflammatory state observed in uremic patients and additionally demonstrated increased peripheral monocytes and inflammatory polarization of adipose tissue macrophages (ATMS). In contrast, adipose tissue in uremic IL-6 knock out mice showed reduced ATMS density compared to uremic wild-type controls. Differences in ATMS density highlight the necessary role of IL-6 in macrophage infiltration in uremia. Uremia promotes changes in adipocytes and macrophages enhancing production of inflammatory cytokines. We demonstrate an interaction between uremic activated macrophages and adipose tissue that augments inflammation in uremia.

Entities:  

Year:  2021        PMID: 33536542     DOI: 10.1038/s41598-021-82685-4

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  48 in total

Review 1.  Inflammation as a cardiovascular risk factor.

Authors:  James T Willerson; Paul M Ridker
Journal:  Circulation       Date:  2004-06-01       Impact factor: 29.690

2.  Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.

Authors:  P Stenvinkel; O Heimbürger; F Paultre; U Diczfalusy; T Wang; L Berglund; T Jogestrand
Journal:  Kidney Int       Date:  1999-05       Impact factor: 10.612

Review 3.  The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia.

Authors:  Jonathan Himmelfarb; Peter Stenvinkel; T Alp Ikizler; Raymond M Hakim
Journal:  Kidney Int       Date:  2002-11       Impact factor: 10.612

Review 4.  Inflammation and vascular calcification.

Authors:  Sharon M Moe; Neal X Chen
Journal:  Blood Purif       Date:  2005       Impact factor: 2.614

5.  Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.

Authors:  J Zimmermann; S Herrlinger; A Pruy; T Metzger; C Wanner
Journal:  Kidney Int       Date:  1999-02       Impact factor: 10.612

6.  Cytokine patterns and survival in haemodialysis patients.

Authors:  Scott D Cohen; Terry M Phillips; Prashant Khetpal; Paul L Kimmel
Journal:  Nephrol Dial Transplant       Date:  2009-12-11       Impact factor: 5.992

7.  Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality.

Authors:  Hirokazu Honda; Abdul Rashid Qureshi; Jonas Axelsson; Olof Heimburger; Mohamed E Suliman; Peter Barany; Peter Stenvinkel; Bengt Lindholm
Journal:  Am J Clin Nutr       Date:  2007-09       Impact factor: 7.045

8.  Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients.

Authors:  Kamyar Kalantar-Zadeh; Gladys Block; Charles J McAllister; Michael H Humphreys; Joel D Kopple
Journal:  Am J Clin Nutr       Date:  2004-08       Impact factor: 7.045

9.  Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease.

Authors:  B Payson Oberg; Elizabeth McMenamin; F Lee Lucas; Ellen McMonagle; Jason Morrow; T Alp Ikizler; Jonathan Himmelfarb
Journal:  Kidney Int       Date:  2004-03       Impact factor: 10.612

10.  The adipose tissue production of adiponectin is increased in end-stage renal disease.

Authors:  Maria P Martinez Cantarin; Scott A Waldman; Cataldo Doria; Adam M Frank; Warren R Maley; Carlo B Ramirez; Scott W Keith; Bonita Falkner
Journal:  Kidney Int       Date:  2013-01-02       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.